Form EFFECT Scinai Immunotherapeutic
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | October 5, 2026 9:00 A.M. |
| Form: | F-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Scinai closes $4M private placement and warrant inducement
- iA Financial Group Chief Legal Officer Isabelle Durand Named In-House Legal Leader of the Year
- Scinai Expands CDMO Business with $5.1 Million Development and Clinical Manufacturing Agreement
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share